Cell death in atherosclerotic plaques

Current Opinion in Lipidology

Volumn 7, Issue 5, 1996, Pages 324-329

  Mitchinson, Malcolm J ^a,b   Hardwick, Simon J ^a   Bennett, Martin R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b Department of Medicine ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL DEATH; HUMAN; MACROPHAGE; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR ENDOTHELIUM;

EID: 0029852550     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199610000-00011     Document Type: Short Survey

References (67)

1. Raff MC: Social controls on cell survival and cell death. Nature 1992, 356:397-400.
2. Geng Y-J, Libby P: Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1β-converting enzyme. Am J Pathol 1995, 147:251-266. Demonstration of apoptosis of SMC and macrophages in human lesions, in surprisingly high frequency, and to a lesser degree in normal artery.
3. Chisolm GM: Cytotoxicity of oxidized lipoproteins. Curr Opin Lipidol 1991, 2:311-316.
4. Old LJ: Tumour necrosis factor (TNF). Science 1985, 230:630-632.
5. Geng Y, Wu Q, Muszynski M, Hansson G, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumour necrosis factor-alpha and interleukin-1-beta. Arterioscler Thromb Vasc Biol 1996; 16:19-27.
6. Xu Q, Luef G, Weimann S, Gupta RS, Wolf H, Wick G: Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler Thromb 1993, 13: 1763-1769.
7. Schett G, Xu Q, Amberger A, Van Der Zee R, Recheis H, Willeit J, Wick G: Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995, 96:2569-2577.
8. Zhu W, Roma P, Pellegatta F, Catapano AL: Oxidised-LDL induce the expression of heat shock protein 70 in human endothelial cells. Biochem Biophys Res Commun 1994, 200:389-394.
9. Zhu WM, Roma P, Pirillo A, Pellegatta F, Catapano AL: Oxidised LDL induce Hsp70 expression in human smooth muscle cells. FEBS Lett 1995, 372:1-5.
10. Evan G, Brown L, Whyte M, Harrington E: Apoptosis and the cell-cycle. Curr Opin Cell Biol 1995, 7:825-834. Outlines recent ideas about the coupling of cell cycle genes to apoptosis, and also provides a model identifying stages of the apoptotic process, with regulators of each stage.
11. Henkart PA. ICE family proteases: mediators of all apoptotic cell death? Immunity 1996; 4:195-201.
12. Araki S, Simada Y, Kaji K, Hayashi H: Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun 1990, 172:1081-1085.
13. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F: Inhibition of anchorage-dependent spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994, 127: 537-546.
14. Meredith J, Fazeli B, Schwartz M: The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4:953-961.
15. Payling Wright H: Mitosis patterns in aortic endothelium. Atherosclerosis 1972, 15:93-100.
16. Reidy MA: A reassessment of endothelial injury and arterial lesion formation. Lab Invest 1985, 53:513-520.
17. Araki S, Shimada Y, Kaji K, Hayashi H: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 1990, 168:1194-1200.
18. Maier J, Morelli D, Balsan A: The differential response to interferon-gamma by normal and transformed endothelial-cells. Biochem Biophys Res Commun 1995, 214:582-588.
19. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P: Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 1991, 138:447-453.
20. Eissner G, Kohlhuber F, Grell M, Ueffing M, Scheurich P, Hieke A, Multhoff G, Bornkamm GW, Holler E: Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 1995, 86: 4184-4193.
21. Haimovitzfriedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I, Fuks Z: Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 1994, 54:2591-2597.
22. Haimovitzfriedman A, Kan C, Ehleiter D, Persaud R, Mcloughlin M, Fuks Z, Kolesnick R: Ionizing-radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994, 180:525-535.
23. Fuks Z, Persaud R, Alfieri A, Mcloughlin M, Ehleiter D, Schwartz J, Seddon A, Cordoncardo C, Haimovitzfriedman A: Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro, and in vivo. Cancer Res 1994, 54:2582-2590.
24. Tee P, Travis E: Basic fibroblast growth factor does not protect against classical radiation pneumonitis in 2 strains of mice. Cancer Res 1995, 55:298-302.
25. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79:1157-1164.
26. Kondo S, Yin D, Aoki T, Takahashi JA, Morimura T, Takeuchi J: bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp Cell Res 1994, 213:428-432.
27. Varani J, Dame MK, Taylor CG, Sarma V, Merino R, Kunkel RG, Nunez G, Dixit VM : Age-dependent injury in human umbilical vein endothelial cells - relationship to apoptosis and correlation with a lack of A20 expression. Lab Invest 1995, 73:851-858.
28. Bochatonpiallat M, Gabbiani F, Redard M, Desmouliere A, Gabbiani G: Apoptosis participates in cellularity regulation during rat aortic intimai thickening. Am J Pathol 1995, 146:1059-1064.
29. Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993, 69:508-517.
30. Alon T, Hemo I, Itin A, Peer J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1995, 1: 1024-1028.
31. Adamis A, Miller J, Bernal M, Damico D, Folkman J, Yeo T, Yeo K: Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450.
32. Choi M, Ballermann B. Inhibition of capillary morphogenesis and associated apoptosis by dominant-negative mutant transforming growth factor beta receptors. J Biol Chem 1995, 270:21144-21150.
33. O'Reilly M, Holmgren L, Shing Y, Chen C, Rosenthal R, Moses M, Lane W, Cao Y, Sage E, Folkman J: Angiostatin - a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328.
34. Salvayre R, Escargueil-Blanc I, Meilhac O, Augé N, Suc I, Mabile L, Thiers J-C, Pieraggi M-T, Nègre-Salvayre A: Endothelial cell damage by mildly oxidised low-density lipoprotein. In Free radicals, lipoprotein oxidation and atherosclerosis. Edited by Bellomo G, Finardi G, Maggi E, Rice-Evans C. London: Richelieu Press; 1995:163-181.
35. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66. A key observation, with analogies for SMC in atherosclerosis.
36. Harrington EA, Bennett MR, Fanidi A, Evan GI: c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 1994, 13: 3286-3295.
37. Bennett MR, Evan GI, Schwartz SM: Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic-plaques. J Clin Invest 1995, 95:2266-2274. The observation that SMC derived from human primary coronary plaques show higher rates of apoptosis in culture than those from normal media. The maintenance of this property in culture implies that plaque cells have a different phenotype to medial cells, and that the proapoptotic tendency is likely to be intrinsic to the cell and thus capable of being inherited. Also demonstrates the importance of growth factors in maintaining SMC viability.
38. Bennett MR, Evan GI, Newby AC: Deregulated c-myc oncogene expression blocks vascular smooth muscle cell inhibition mediated by heparin, interferon-y, mitogen depletion and cyclic nucleotide analogues and induces apoptotic cell death. Circ Res 1994, 74:525-536.
39. Bennett MR, Evan GI, Schwartz SM: Apoptosis of rat vascular smooth muscle cells is regulated by p53 dependent and independent pathways. Circ Res 1995, 77:266-273.
40. Harrington E, Fanidi A, Evan G: Oncogenes and cell death. Curr Opin Genet Dev 1994, 4:120-129.
41. Packham G, Cleveland JL: Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 1994, 14:5741-5747.
42. Björkerud B, Björkerud S: Contrary effects of lightly and strongly oxidised LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages and fibroblasts. Arterioscler Thromb Vasc Biol 1996, 16:416-424.
43. Cho A, Courtman D, Langille L: Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res 1995, 76:168-175.
44. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G: Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995, 147:267-277. Another early description of apoptosis in human lesions, at high frequency.
45. Isner J, Kearney M, Bortman S, Passeri J: Apoptosis in human atherosclerosis and restenosis. Circulation 1995, 91:2703-2711. The interesting, counter-intuitive observation that apoptosis may occur at higher frequencies in restenosis, and thus apoptosis may promote vessel wall stability. The frequencies are far lower than in some accounts.
46. Hegyi L, Skepper JN, Cary NRB, Mitchinson MJ: Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol 1996, (In press).
47. Thomas WA, Reiner JM, Florentin FA, Lee KT, Lee WM: Population dynamics of arterial smooth muscle cells. V. Cell proliferation and cell death during initial 3 months in atherosclerotic lesions induced in swine by hypercholesterolemic diet and intimai trauma. Exp Mol Pathol 1976, 24:360-374.
48. Thomas W, Kim D, Lee K, Reiner J, Schmee J: Population dynamics of arterial cells during atherogenesis. XIII. Mitogenic and cytotoxic effects of a hyperlipidaemic (HL) diet on cells in advanced lesions in the abdominal aortas of swine fed an HL diet for 270-345 days. Exp Mol Pathol 1983, 39:257-270.
49. Ball RY, Stowers EC, Burton JH, Cary NRB, Skepper JN, Mitchinson MJ: Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis 1995, 114:45-54. Demonstration of macrophage foam cell contents in the lipid core of human advanced lesions, proving that macrophage death contributes to the core.
50. Guyton JR, Klemp KF: Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 1996, 16:4-11.
51. Berberian PA, Myers W, Tytell M, Challa V, Bond MG: Immunohistochemical localization of heat-shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol 1990, 136:71-80.
52. Reid VC, Mitchinson MJ: Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 1993, 98:17-24.
53. Marchant CE, Law NS, Van der Veen C, Hardwick SJ, Carpenter KLH, Mitchinson MJ: Oxidised low density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants. FEBS Lett 1995, 358:175-178.
54. Reid VC, Mitchinson MJ, Skepper JN: Cytotoxicity of oxidised low density lipoprotein to mouse peritoneal macrophages: an ultrastructural study. J Pathol 1993, 171:321-328.
55. Hardwick SJ, Hegyi L, Clare K, Law NS, Carpenter KLH, Mitchinson MJ, Skepper JN: Apoptosis in human monocyte-macrophages exposed to oxidised low density lipoprotein. J Path 1996, 179:294-302.
56. Reid VC, Hardwick SJ, Mitchinson MJ: Fragmentation of DNA in P388D1 macrophages exposed to oxidised low density lipoprotein. FEBS Lett 1993, 332:218-220.
57. Marchant CE, Van der Veen C, Law NS, Hardwick SJ, Carpenter KLH, Mitchinson MJ: Oxidation of low density lipoprotein by human monocyte-macrophages results in toxicity to the oxidising culture. Free Rad Res 1996, 24:333-342.
58. Braesen JH, Beisiegel U, Niendorf A: Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbit. Virchows Arch 1995, 426: 179-188. The failure of probucol-treated animals to develop a lipid core, suggesting that oxidative processes are necessary for its origin.
59. Chang MY, Sasahara M, Chait A, Raines EW, Ross R: Inhibition of hypercholesterolemia-induced atherosclerosis in the non-human primate by probucol. II. Cellular composition and proliferation. Arterioscler Thromb Vasc Biol 1995, 15:1631-1640.
60. Clare K, Hardwick SJ, Carpenter KLH, Weeratunge N, Mitchinson MJ: Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis 1995, 118:67-75.
61. Carpenter KLH, Taylor SE, Van der Veen C, Williamson BK, Ballantine JA, Mitchinson MJ: Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta 1995, 1256:141-150.
62. Carpenter KLH, Taylor SE, Ballantine JA, Fussell B, Halliwell B, Mitchinson MJ: Lipids and oxidised lipids in human atheroma and normal aorta. Biochim Biophys Acta 1993, 1167:121-130.
63. Chisolm GM, Ma G, Irwin KC, Martin LL, Gundersson KG, Lynberg LF, Morel DW, Dicorleto PE: 7β-Hydroperoxycholest-5-en-3β-ol, a component of atherosclerotic lesions, is the primary cytotoxin of oxidised human low density lipoprotein. Proc Natl Acad Sci U S A 1994, 91: 11452-11456.
64. Coffey MD, Cole RA, Colles SM, Chisolm GM: In vitro cell injury by oxidised low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid and peroxyl radicals. J Clin Invest 1995, 96:1866-1873.
65. Carpenter KLH, Ball RY, Ardeshna KM, Bindman JP, Enright JH, Hartley SL, Nicholson S, Mitchinson MJ: Production of ceroid and oxidised lipids by macrophages In vitro. In Lipofuscin 1987 - state of the Art. Edited by Nagy IZ. Amsterdam: Elsevier; 1988:245-268.
66. Reid VC, Brabbs CE, Mitchinson MJ: Cellular damage in mouse peritoneal macrophages exposed to cholesteryl linoleate. Atherosclerosis 1992, 92:251-260.
67. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991, 11:81-128.